
{
  "BCG": {
    "Scheduled Age": "At birth (0 weeks)",
    "Protects Against": "Severe forms of tuberculosis (TB), especially TB meningitis and miliary TB in children",
    "Type": "Live attenuated vaccine",
    "Route": "Intradermal injection (usually left upper arm)",
    "Common Side Effects": [
      "Local ulcer at the injection site (healing within weeks)",
      "Swollen lymph nodes"
    ],
    "Special Considerations": [
      "Scar formation is common and expected",
      "Not given to infants with symptomatic HIV infection"
    ]
  },
  "OPV": {
    "Scheduled Age": "0 weeks, 6 weeks, 10 weeks, 14 weeks",
    "Protects Against": "Poliomyelitis (polio)",
    "Type": "Live attenuated oral vaccine",
    "Route": "Oral drops",
    "Common Side Effects": [
      "Usually none",
      "Rarely mild fever or diarrhea"
    ],
    "Special Considerations": [
      "Part of global eradication efforts",
      "Contraindicated in immunocompromised children and household contacts",
      "May be replaced with IPV in some regions due to vaccine-derived polio risk"
    ]
  },
  "Rotavirus": {
    "Scheduled Age": "6 weeks, 10 weeks",
    "Protects Against": "Severe rotavirus diarrhea, especially in infants and young children",
    "Type": "Live attenuated oral vaccine",
    "Route": "Oral drops",
    "Common Side Effects": [
      "Mild, temporary diarrhea or irritability",
      "Very rare risk of intussusception (bowel obstruction)"
    ],
    "Special Considerations": [
      "Must be given before 8 months of age",
      "Do not re-administer if the baby spits it out or vomits after the dose"
    ]
  },
  "Pneumo_conj": {
    "Scheduled Age": "6 weeks, 10 weeks, 14 weeks",
    "Protects Against": "Invasive pneumococcal diseases such as meningitis, pneumonia, and sepsis",
    "Type": "Inactivated conjugate vaccine",
    "Route": "Intramuscular injection (thigh or upper arm)",
    "Common Side Effects": [
      "Mild fever",
      "Redness or swelling at injection site",
      "Fussiness or drowsiness"
    ],
    "Special Considerations": [
      "Very important for children under 2 years",
      "Some countries use a booster dose later (e.g. 9 months or 12 months)"
    ]
  },
  "DTwPHibHepB": {
    "Scheduled Age": "6 weeks, 10 weeks, 14 weeks",
    "Protects Against": [
      "Diphtheria",
      "Tetanus",
      "Pertussis (whooping cough)",
      "Haemophilus influenzae type b (Hib)",
      "Hepatitis B"
    ],
    "Type": "Inactivated combination vaccine",
    "Route": "Intramuscular injection",
    "Common Side Effects": [
      "Fever",
      "Pain, redness, or swelling at injection site",
      "Irritability or drowsiness"
    ],
    "Special Considerations": [
      "Replaces the need for separate doses of HepB, Hib, DTP",
      "Fever may be more pronounced due to whole-cell pertussis"
    ]
  },
  "IPV": {
    "Scheduled Age": "14 weeks",
    "Protects Against": "Poliomyelitis (polio)",
    "Type": "Inactivated (killed) vaccine",
    "Route": "Intramuscular or subcutaneous injection",
    "Common Side Effects": [
      "Soreness at the injection site",
      "Mild fever"
    ],
    "Special Considerations": [
      "Used in combination with OPV for greater protection",
      "Does not carry a risk of vaccine-derived polio"
    ]
  },
  "Yellow Fever": {
    "Scheduled Age": "9 months",
    "Protects Against": "Yellow fever virus (transmitted by mosquitoes)",
    "Type": "Live attenuated vaccine",
    "Route": "Subcutaneous injection",
    "Common Side Effects": [
      "Mild fever",
      "Headache",
      "Muscle aches"
    ],
    "Special Considerations": [
      "Required for travel to or from certain countries (international certificate)",
      "Lifelong immunity for most individuals",
      "Not given to immunocompromised children"
    ]
  },
  "Measles": {
    "Scheduled Age": "9 months, 18 months",
    "Protects Against": "Measles (and Rubella/Mumps if combined)",
    "Type": "Live attenuated vaccine",
    "Route": "Subcutaneous injection",
    "Common Side Effects": [
      "Fever and mild rash 5–12 days after vaccination",
      "Rare allergic reactions"
    ],
    "Special Considerations": [
      "First dose provides ~85% protection; second dose boosts to >95%",
      "Should be delayed in children with severe immunosuppression"
    ]
  },
  "HPV": {
    "Scheduled Age": "10 years, 10 years 6 months",
    "Protects Against": [
      "Cervical cancer",
      "Other HPV-related cancers (anal, penile, throat)",
      "Genital warts"
    ],
    "Type": "Recombinant vaccine (non-live)",
    "Route": "Intramuscular injection (arm)",
    "Common Side Effects": [
      "Pain or swelling at the injection site",
      "Dizziness or fainting"
    ],
    "Special Considerations": [
      "Most effective when given before the onset of sexual activity",
      "2-dose schedule for ages 9–14; 3-dose for 15 years and above"
    ]
  }
}

